(Date:12/6/2009)... harvested from San Antonio Bay ,, SILVER SPRING, ... Drug Administration is advising consumers to avoid eating oysters ... Nov. 16 due to reports of norovirus-associated illnesses in ... area, which is located on the Gulf of Texas. ... The FDA, along with the Centers for Disease Control ...
(Date:12/6/2009)... Findings offer hope for future treatments targeting growth factor, ... -- The spread of breast cancer cells from the ... controlled by a growth factor known as TGFb, which ... prevent metastatic breast cancer, British researchers say. , Previous ... regulates normal cell growth and movement. In this new ...
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Onyx Pharmaceuticals, ... safety data from the pivotal Phase 2b 003-A1 ... carfilzomib is well-tolerated in heavily pre-treated relapsed and ... today at the ASH/ASCO Joint Symposium at the ... Hematology (ASH) in New Orleans. Enrollment in this ...
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/6/2009)... dangerous substances such as asbestos have been found in toys in ... ... December 6, 2009 -- As parents shop for children,s toys during ... due to lead paint or asbestos contamination, says a New York ... rooms each year due to toy-related injuries,” says Joseph W. Belluck, ...
Breaking Medicine News(10 mins):Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:Breast Cancer's Spread Now Better Understood 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3... 12 Rite Aid Corporation (Rite Aid) and nine ... pay $5 million in civil penalties to settle allegations ... Department of Justice announced today. In addition to the ... subsidiaries agreed to a compliance plan with the U.S. ...
... EDITOR,S PICK: Opiods provide relief from neuropathic pain ... nerves, such as caused by the trauma of amputation, ... can be extremely debilitating, and treatments show limited or ... with an inflammatory response, and immune cells are thought ...
... Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH) announced ... has been appointed to its Board of Directors. ... other publicly traded,companies. , "Betsy ... leading,large, consumer-facing organizations in competitive, highly regulated,markets," said John ...
... Americans in Fighting the Country,s Most Common DisabilityATLANTA, Jan. ... of Let,s Move Together , a nationwide movement ... one-in-five Americans living with the pain of arthritis.To view ... Let,s Move Together is designed to inspire ...
... Stereotaxis, Inc.,(Nasdaq: STXS ) today announced ... the RF PowerAssert(TM) Magnetic Guidewire. Cleared by ... RF PowerAssert guidewire is the only,magnetically enabled device ... with the Niobe Magnetic Navigation System, it is ...
... eyes read 29 words per minute slower , , MONDAY, ... reading problems in older adults, a new report shows. , ... found people with glaucoma in both eyes (bilateral) read 29 ... were almost twice as likely to have reading impairment. , ...
Other Medicine News:Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 4Health News:JCI online early table of contents: Jan. 12, 2009 2Health News:JCI online early table of contents: Jan. 12, 2009 3Health News:JCI online early table of contents: Jan. 12, 2009 4Health News:JCI online early table of contents: Jan. 12, 2009 5Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 2Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 3Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 2Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 3Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 2Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 3... (Nasdaq: ANDS ) presented a late-breaker oral ... Research (ICAR) in Montreal,Quebec, providing updated preclinical data ... virus (HCV) NS5b polymerase., The presentation reported ... for beneficial combination of the product candidate,with several ...
... study at Rice Memorial Hospital translates into ... of pharmacist and nursing staff, MOUNTAIN VIEW, Calif. ... OMCL ) a leading provider,of system solutions targeting patient ... Hospital, a major healthcare,facility in West Central Minnesota, today ...
Other Medicine Technology:Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research 2Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research 3RICE MEMORIAL HOSPITAL PHARMACY STAFF EXPERIENCES A 55% REDUCTION IN TIME SPENT MANAGING PATIENT-SPECIFIC MEDICATIONS USING OMNICELL SINGLEPOINTE SOLUTION 2RICE MEMORIAL HOSPITAL PHARMACY STAFF EXPERIENCES A 55% REDUCTION IN TIME SPENT MANAGING PATIENT-SPECIFIC MEDICATIONS USING OMNICELL SINGLEPOINTE SOLUTION 3... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: